ASCOLT trial explores aspirin’s role in preventing colorectal cancer recurrence

ASCOLT trial explores aspirin’s role in preventing colorectal cancer recurrence

Source: News-Medical.Net

A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer has concluded.

A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer has concluded. Led by Singapore clinician-scientists, the ASCOLT (Aspirin after completion of standard adjuvant therapy for… [8128 chars]

Read more